DrugPatentWatch Database Preview
Patent: 10,322,162
Summary for Patent: 10,322,162
| Title: | Methods and pharmaceutical compositions for the treatment of ischemic conditions |
| Abstract: | The present invention relates to methods and pharmaceutical compositions for the treatment of ischemic conditions. In particular, the present invention relates to a method of treating an ischemic condition in a subject in need thereof comprising administering the subject with a polypeptide comprising an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino acid residue at position 186 to the amino acid residue at position 406 in SEQ ID NO: 1. |
| Inventor(s): | Germain; Stephane (Paris, FR), Berdeaux; Alain (Creteil, FR), Tissier; Renaud (Creteil, FR), Ghaleh-Marzban; Bijan (Creteil, FR), Monnot; Catherine (Paris, FR), Galaup; Ariane (Paris, FR) |
| Assignee: | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (Paris, FR) ECOLE NATIONALE VETERINAIRE D\'ALFORT (ENVA) (Maisons-Alfort, FR) |
| Application Number: | 15/541,422 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,322,162
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | ACTIVASE | alteplase | VIAL; SINGLE-USE | 103172 | 001 | 1987-11-13 | Start Trial | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI | 2035-01-06 | RX | search | |
| Genentech | ACTIVASE | alteplase | VIAL; SINGLE-USE | 103172 | 002 | 1987-11-13 | Start Trial | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI | 2035-01-06 | RX | search | |
| Genentech | CATHFLO ACTIVASE | alteplase | VIAL | 103172 | 003 | 1987-11-13 | Start Trial | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI | 2035-01-06 | RX | search | |
| Ekr Therap | RETAVASE | reteplase | VIAL | 103786 | 001 | 1998-05-06 | Start Trial | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI | 2035-01-06 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
